Welcome to QualMatters
If DRd, DKd, KRd, or IKd in 1L RRMM BTZ refractory patients, which Tx in 2L+?
We know what you are talking about!
About us
QualMatters is an experienced fieldwork agency specializing in primary and secondary qualitative projects for market research and consulting companies commissioned by the pharmaceutical, biotechnological, and medical devices industries.
.
If DRd, DKd, KRd, or IKd in 1L RRMM BTZ refractory patients, which Tx in 2L+?
If needed ; - ):
If daratumumab+lenalidomide+dexamethasone, daratumumab+carfilzomib+dexamethasone, carfilzomib+lenalidomide+dexamethasose, or isatuximab+carfilzomib+dexamethasone is used in the frontline relapse/refractory multiple myeloma setting in bortezomib-refractory patients, what will be the treatment in the second and subsequent lines?